{"AllianceGenome": "5217", "HGNC": "5217", "MIM": "109715", "_id": "3283", "_version": 1, "accession": {"genomic": ["AH001481.2", "AH002586.2", "AL121995.12", "CH471122.1", "CP068277.2", "HC007030.1", "M38180.1", "NC_000001.11", "NC_060925.1", "NG_050909.1"], "protein": ["AAA36001.1", "AAA36015.1", "AAA51538.1", "AAA51662.1", "AAA51831.1", "AAB23543.1", "AAH31999.1", "BAF84245.1", "CAA37408.1", "CAA39469.1", "CBH19320.1", "EAW56703.1", "EAW56704.1", "NP_000853.1", "NP_001315544.1", "P14060.2"], "rna": ["AK291556.1", "AL544564.3", "AL550307.3", "BC031999.1", "M27137.1", "M35493.1", "NM_000862.3", "NM_001328615.1", "S45679.1", "X53321.1", "X55997.1"], "translation": [{"protein": "AAA36015.1", "rna": "M27137.1"}, {"protein": "AAA51538.1", "rna": "M35493.1"}, {"protein": "NP_000853.1", "rna": "NM_000862.3"}, {"protein": "AAH31999.1", "rna": "BC031999.1"}, {"protein": "CAA37408.1", "rna": "X53321.1"}, {"protein": "CAA39469.1", "rna": "X55997.1"}, {"protein": "NP_001315544.1", "rna": "NM_001328615.1"}, {"protein": "BAF84245.1", "rna": "AK291556.1"}, {"protein": "AAB23543.1", "rna": "S45679.1"}]}, "alias": ["3BETAHSD", "HSD3B", "HSDB3", "HSDB3A", "SDR11E1"], "ec": ["1.1.1.145", "1.1.1.210", "1.1.1.270", "5.3.3.1"], "ensembl": {"gene": "ENSG00000203857", "protein": ["ENSP00000358421", "ENSP00000432268", "ENSP00000435999"], "transcript": ["ENST00000369413", "ENST00000487520", "ENST00000492140", "ENST00000528909", "ENST00000531340"], "translation": [{"protein": "ENSP00000435999", "rna": "ENST00000531340"}, {"protein": "ENSP00000358421", "rna": "ENST00000369413"}, {"protein": "ENSP00000432268", "rna": "ENST00000528909"}], "type_of_gene": "protein_coding"}, "entrezgene": "3283", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.17338345, "exp_mis": 124.1760349, "exp_syn": 59.465156, "lof_z": 1.18487443456598, "mis_z": -1.52853816225258, "mu_lof": 9.63450422769e-07, "mu_mis": 1.08487625223e-05, "mu_syn": 5.13740511642e-06, "n_lof": 8.0, "n_mis": 159.0, "n_syn": 73.0, "p_li": 8.51173207421434e-05, "p_null": 0.225605895979325, "p_rec": 0.774308986699933, "syn_z": -1.08810617694737}, "bp": 1122, "cds_end": 120057268, "cds_start": 120050099, "n_exons": 3, "nonpsych": {"exp_lof": 10.9561801, "exp_mis": 112.3293908, "exp_syn": 53.7597973, "lof_z": 1.47051508893158, "mis_z": -1.41202140269339, "mu_lof": 9.63450422769e-07, "mu_mis": 1.08487625223e-05, "mu_syn": 5.13740511642e-06, "n_lof": 6.0, "n_mis": 142.0, "n_syn": 65.0, "p_li": 0.00192511181947864, "p_null": 0.107344090386021, "p_rec": 0.8907307977945, "syn_z": -0.965180859911463}, "nontcga": {"exp_lof": 11.19347914, "exp_mis": 114.2359262, "exp_syn": 54.70191126, "lof_z": 1.53128864107891, "mis_z": -1.4340103981032, "mu_lof": 9.63450422769e-07, "mu_mis": 1.08487625223e-05, "mu_syn": 5.13740511642e-06, "n_lof": 6.0, "n_mis": 145.0, "n_syn": 68.0, "p_li": 0.00194975286389029, "p_null": 0.0903226040945464, "p_rec": 0.907727643041563, "syn_z": -1.13844041948018}, "transcript": "ENST00000369413.3"}, "exons": [{"cdsend": 119514645, "cdsstart": 119507476, "chr": "1", "position": [[119507209, 119507262], [119507391, 119507621], [119511502, 119511667], [119513833, 119515054]], "strand": 1, "transcript": "NM_000862", "txend": 119515054, "txstart": 119507209}, {"cdsend": 119514645, "cdsstart": 119507476, "chr": "1", "position": [[119507202, 119507212], [119507391, 119507621], [119511502, 119511667], [119513833, 119515058]], "strand": 1, "transcript": "NM_001328615", "txend": 119515058, "txstart": 119507202}], "exons_hg19": [{"cdsend": 120057268, "cdsstart": 120050099, "chr": "1", "position": [[120049832, 120049885], [120050014, 120050244], [120054125, 120054290], [120056456, 120057677]], "strand": 1, "transcript": "NM_000862", "txend": 120057677, "txstart": 120049832}, {"cdsend": 120057268, "cdsstart": 120050099, "chr": "1", "position": [[120049825, 120049835], [120050014, 120050244], [120054125, 120054290], [120056456, 120057681]], "strand": 1, "transcript": "NM_001328615", "txend": 120057681, "txstart": 120049825}], "generif": [{"pubmed": 11912155, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12050213, "text": "nonstop mutation in the stop codon and missense mutation in type II 3beta-hydroxysteroid dehydrogenase gene causing 3beta-HSD deficiency congenital adrenal hyperplasia."}, {"pubmed": 12054649, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12054649, "text": "Polymorphism in exon 4 of the human gene and blood presssure"}, {"pubmed": 12205101, "text": "Structure/function relationships responsible for the kinetic differences between isoforms"}, {"pubmed": 12438565, "text": "HSD3B1 was identified using a trifunctional phenyl sulfonate probe."}, {"pubmed": 12530651, "text": "Substantially higher affinity of 3beta-HSD1 activity for substrate and inhibitor steroids relative to the 3beta-HSD2 enzyme."}, {"pubmed": 12530676, "text": "In outer region of adrenal cortex immunoreactivity was observed for 3beta-hydroxysteroid dehydrogenase."}, {"pubmed": 12832414, "text": "Structure/function relationships responsible for coenzyme specificity and the isomerase activity of this multienzyme complex."}, {"pubmed": 14764797, "text": "Descending HSD3B phenotype in hyperandrogenic females is associated with a variant of insulin-resistant polycystic ovary syndrome."}, {"pubmed": 15097232, "text": "Neither of the HSD3B1 or PTP1B variants were associated with hypertension"}, {"pubmed": 15097232, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15291746, "text": "results designate YY1 as the factor responsible for the intron 1-mediated boost of the HSD3B2 gene basal promoter activity"}, {"pubmed": 15291757, "text": "further characterizes structure/function relationships of human 3beta-HSD and bring us closer to the goal of selectively inhibiting the type 1 enzyme in placenta to control the timing of labor or in hormone-sensitive breast tumors to slow their growth"}, {"pubmed": 15797861, "text": "identification of structural reasons for the substantially higher affinities of 3beta-HSD1 for substrates, coenzymes, and inhibitors"}, {"pubmed": 16302261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17507624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17589376, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17624763, "text": "The Rossmann-fold domain of 3beta-HSD1 contains two Cys residues, Cys72 and Cys111, which are capable of forming an intrasubunit disulfide bond based on their proximity in our structural model."}, {"pubmed": 17627014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17627014, "text": "Variant in the HSD3B1 gene is associated with increased mammographic density"}, {"pubmed": 17689071, "text": "There is a possible role in human disease of common genetic variation in HSD3B1 and HSD3B2."}, {"pubmed": 17826523, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17826523, "text": "results suggest that the HSD3B1 N367T and UGT2B17 null polymorphisms may modify the risk of prostate cancer, particularly among men with a family history of the disease"}, {"pubmed": 18223326, "text": "HSD3B1 is highly specific and sensitive compared with other trophoblastic markers dor differential diagnosis of trophoblastic tumors and tumorlike lesions.."}, {"pubmed": 18281655, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18281655, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18524572, "text": "Structure/function of the inhibition of HSD3B1 by trilostane is reported."}, {"pubmed": 18636124, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18723074, "text": "The activity levels of 17beta-hydroxysteroid dehydrogenase (17beta-HSD), 3beta-hydroxysteroid dehydrogenase (3beta-HSD), 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD/3-KSR) and estrone sulfatase in ovarian epithelial carcinomas, were assayed."}, {"pubmed": 18778748, "text": "Anti-inflammatory effects of IL-1alpha and IL-4 on 3beta-HSD2 mRNA involve a p38 MAPK signalling pathway, whereas pro-inflammatory response of IL-1alpha to 3beta-HSD1 mRNA involves a NF-kappaB inflammatory pathway."}, {"pubmed": 18955108, "text": "The high affinity, competitive inhibition of 3beta-HSD1 by trilostane and epostane may be related to the presence of Arg195 in 3beta-HSD1 vs. Pro195 in 3beta-HSD2."}, {"pubmed": 19148546, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19148546, "text": "The genetic polymorphisms of the HSD3B1,genes were found to be significantly different (p<0.05) between the uremic and non-uremic diabetes group"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19197249, "text": "Among patients with essential hypertension, cholesterol side-chain cleavage & MDR1 loci are related to circulating endogenous ouabain & DBP. In contrast, variants in HSD3B1 are related with SBP probably via aldosterone"}, {"pubmed": 19197249, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336370, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19414525, "text": "3beta-HSD protein was immunodetectable in primary ascites of women who were diagnosed with epithelial ovarian cancer but mRNA transcripts of both 3beta-hydroxysteroid dehydrogenase type 1 and type 2 were diminished relative to normal cells."}, {"pubmed": 19429456, "text": "compared (+)- and (-)-gossypols in the inhibition of 3beta-HSD and 17beta-HSD3 in human and rat testes"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19505920, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19574343, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20056642, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20056642, "text": "We investigated associations between single nucleotide polymorphisms in genes HSD3B1, SRD5A1/2, and AKR1C2 and prostate cancer risk"}, {"pubmed": 20086173, "text": "Data indicate that enzymes CYP17A1 and HSD3B1 showed low expression, while AKR1C3 and SRD5A1 were abundantly expressed."}, {"pubmed": 20184498, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20214802, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20420909, "text": "The study identifies an amino acid in the steroid binding domain of human 3-beta-HSD I that may be exploited to produce new inhibitors that are much more highly specific for 3-beta-HSD I in breast tumors compared to adrenal 3-beta-HSD II."}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20660004, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20660004, "text": "rs6203 and rs1047303 in the HSD3B1 gene are useful genetic markers for essential hypertension, while polymorphisms of HSD3B1 are associated with the BP and aldosterone level."}, {"pubmed": 20729390, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20877624, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21631238, "text": "The HSD3B1 T/C polymorphism cannot be used as genetic marker for the risk for recurrent spontaneous abortions in our Caucasian population."}, {"pubmed": 21932034, "text": "There is expression of 3beta-Hsd1 in XX gonads during gonad differentiation period."}, {"pubmed": 22638611, "text": "The aim of this haplotype-based case-control study was to estimate whether polymorphisms of the maternal estrogen synthesis genes (CYP19A1, HSD3B1 and HSD3B2) are associated with preeclampsia and gestational hypertension"}, {"pubmed": 22673022, "text": "Carriers of HSD3B1 GCC haplotype had lower peak early (Ea; P = 0.004) and higher peak late (Aa; P = 0.066) diastolic mitral annular velocities and therefore a lower Ea/Aa ratio (P = 0.041) as compared with noncarriers"}, {"pubmed": 23122578, "text": "elevated in placental tissue of women with polycystic ovarian syndrome"}, {"pubmed": 23318910, "text": "HSD3B1 is a highly specific trophoblast-associated marker that can be used in the distinction of trophoblastic tumorlike lesions and tumors from nontrophoblastic lesions and tumors."}, {"pubmed": 23859711, "text": "HSD3B1 T-->C Leu338, HTR2A T102C, GNAS T393C, and RGS2 G638A polymorphisms were not associated with hypertension risk."}, {"pubmed": 23993097, "text": "Study shows that castration-resistant prostate cancer sometimes expresses a gain-of-stability mutation that leads to a gain-of-function in 3betaHSD1, which catalyzes the initial rate-limiting step in conversion of the adrenal-derived steroid dehydroepiandrosterone to dihydrotestosterone."}, {"pubmed": 24006038, "text": "Risk-conferring genetic variations in the HSD3beta gene influenced susceptibility of primary aldosteronism. Concomitant presence of rs6203 CC and rs12410453 GA genotypes synergistically increased aldosterone-to-renin ratio"}, {"pubmed": 24157973, "text": "The AAT haplotype of the HSD3B1 gene was significantly associated with increased risks of acne vulgaris in Han Chinese from the Southwest China."}, {"pubmed": 24810473, "text": "Expression of the genes HSD3B1, HSD17B3, and SRD5A2 was significantly increased in BPH tissues compared to normal adjacent prostate tissues."}, {"pubmed": 24951726, "text": "No evidence to support that HSD3B1 is involved in aldosterone synthesis in the human adrenal cortex or that genetic variation in HSD3B1 affects blood pressure or hypertension."}, {"pubmed": 25092869, "text": "The AngII-NGFIB/NURR1 pathway controls HSD3B1 expression."}, {"pubmed": 25172194, "text": "The data of this study supports a strongly positive association between mitochondrial complex I gene variations and MS pathogenesis in a Filipino population."}, {"pubmed": 25319929, "text": "Results indicate that orexin-A significantly enhanced the expression of 3beta-hydroxysteroid dehydrogenase (3beta-HSD) and the production of cortisol, and increased the phosphorylation of AKT protein in the NCI-H295R adrenocortical cells."}, {"pubmed": 25458695, "text": "HSD3B1 is involved in aldosterone production, despite its lower levels of expression compared with HSD3B2, and also possibly associated with KCNJ5 mutation in aldosterone-producing adenoma."}, {"pubmed": 25731771, "text": "prostate cancer patients who harbored the heterozygous variant HSD3B1 (1245C) are more likely to develop to castration-resistant prostate cancer but do not have shorter time to biochemical recurrence, shorter survival time or higher mortality risk"}, {"pubmed": 27139182, "text": "This is the first study to indicate that 3beta-HSD type 1 is a potent prognostic factor in hormone-dependent breast cancer."}, {"pubmed": 28655875, "text": "This study identified GATA motifs as essential control elements for HSD3B1 transcription and GATA2 as a novel transcriptional regulator of HSD3B1 expression in the human placenta."}, {"pubmed": 28744792, "text": "High HSD3B1 Expression is Associated with Cancer Progression in Breast Cancer."}, {"pubmed": 28951168, "text": "Fungicide ziram may disrupt the placental steroid production. In the present study, we investigated the effects of ziram on steroid formation in human placental cell line JEG-3 cells and on HSD3B1 and aromatase in the human placenta. Ziram did not inhibit progesterone production in JEG-3 cells and HSD3B1 activity at 100muM...  ziram is a potent inhibitor of human aromatase."}, {"pubmed": 29049452, "text": "Inheritance of the HSD3B1 (1245C) variant allele, which is a predictive biomarker of resistance to castration, is also a predictive biomarker of sensitivity to extragonadal androgen ablation with a nonsteroidal CYP17A1 inhibitor. These findings signal a possible pathway of treatment stratification for patients with prostate cancer."}, {"pubmed": 29049492, "text": "The HSD3B1 (1245C) allele was associated with more rapid development of metastases in men treated with Androgen-deprivation therapy for biochemical recurrence after primary radiation therapy for prostate cancer."}, {"pubmed": 29939161, "text": "Increased generation of 3-keto-5alpha-abiraterone in patients with HSD3B1(1245C) might partially negate abiraterone benefits in these patients who are otherwise more likely to benefit from CYP17A1 inhibition."}, {"pubmed": 30794306, "text": "Studied association between genetic variants in hydroxy-delta-5-steroid dehydrogenase 3 (HSD3B1) and outcome in Japanese men treated with primary androgen-deprivation therapy for metastatic hormone-sensitive prostate cancer as well as abiraterone for castration-resistant prostate cancer."}, {"pubmed": 31004874, "text": "Study found that HSD3B1 silencing modulates the expression of growth factors and cytokines in triple-negative breast cancer cells. Either genetic or pharmacologic inhibition of HSD3B1 suppresses IL-6 expression and secretion, and HSD3B1 inhibition reduces colony formation, which was partially rescued by IL-6 supplementation."}, {"pubmed": 31056381, "text": "The presence of female pattern hair loss was higher in overweight women with polycystic ovary syndrome who comprised HSD3B1 AC or CC genotype compared with wild type."}, {"pubmed": 31187330, "text": "Collectively, PAPPA, LHCGR, and AREG mRNA levels in CC may be able to identify oocytes with the best odds of resulting in a live birth, and HSD3B1 mRNA levels may be able to identify oocytes capable of producing euploid embryos"}, {"pubmed": 31271415, "text": "adrenal-permissive HSD3B1(1245C) genotype is associated with inferior outcomes after androgen deprivation therapy for advanced prostate cancer, and increased sensitivity to pharmacologic blockade of adrenal precursors in metastatic disease."}, {"pubmed": 31331867, "text": "The variant allele 1245C of the HSD3B1 gene is present in approximately one-half of patients with CRPC; however, it is not associated with oncologic outcomes."}, {"pubmed": 31351905, "text": "review of gene regulation, biochemistry, subcellular location in placenta and inhibitors from the environment"}, {"pubmed": 31849283, "text": "Germline variants and response to systemic therapy in advanced prostate cancer."}, {"pubmed": 31932420, "text": "HSD3B1 genotype were associated glucocorticoid responsiveness in treating severe asthma."}, {"pubmed": 32053149, "text": "HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer."}, {"pubmed": 32866512, "text": "Germline HSD3B1 Genetics and Prostate Cancer Outcomes."}, {"pubmed": 33141329, "text": "HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer."}, {"pubmed": 33639023, "text": "miR-27b-5p inhibits BeWo cells fusion by regulating WNT2B and enzyme involved in progesterone synthesis."}, {"pubmed": 33649516, "text": "The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer."}, {"pubmed": 34520399, "text": "Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer."}, {"pubmed": 34747051, "text": "Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer."}, {"pubmed": 35521709, "text": "Inheritance of a common androgen synthesis variant allele is associated with female COVID susceptibility in UK Biobank."}, {"pubmed": 35776258, "text": "Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer."}, {"pubmed": 35795973, "text": "Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk."}, {"pubmed": 35947687, "text": "Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer."}, {"pubmed": 36362361, "text": "HSD3B1 Expression Is Upregulated by Interleukin 4 in HT-29 Colon Cancer Cells via Multiple Signaling Pathways."}, {"pubmed": 37132223, "text": "HSD3B1 is an oxysterol 3beta-hydroxysteroid dehydrogenase in human placenta."}, {"pubmed": 37274334, "text": "High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians."}, {"pubmed": 37966114, "text": "Intratumoral androgen biosynthesis associated with 3beta-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer."}, {"pubmed": 38506808, "text": "Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes."}, {"pubmed": 38506812, "text": "Adrenal-Permissive HSD3B1 Genotype-An Invisible Stimulator of Prostate Cancer Mortality."}], "genomic_pos": {"chr": "1", "end": 119515054, "ensemblgene": "ENSG00000203857", "start": 119507198, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 120057681, "start": 120049821, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006694", "qualifier": "involved_in", "term": "steroid biosynthetic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006694", "pubmed": 1944309, "qualifier": "involved_in", "term": "steroid biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006702", "pubmed": 1944309, "qualifier": "involved_in", "term": "androgen biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006703", "pubmed": 1944309, "qualifier": "involved_in", "term": "estrogen biosynthetic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0008207", "qualifier": "involved_in", "term": "C21-steroid hormone metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0021766", "qualifier": "involved_in", "term": "hippocampus development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0051412", "qualifier": "involved_in", "term": "response to corticosterone"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005743", "pubmed": 8274411, "qualifier": "located_in", "term": "mitochondrial inner membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005758", "pubmed": 8274411, "qualifier": "located_in", "term": "mitochondrial intermembrane space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0030868", "qualifier": "located_in", "term": "smooth endoplasmic reticulum membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "is_active_in", "term": "intracellular membrane-bounded organelle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045171", "qualifier": "located_in", "term": "intercellular bridge"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0000253", "qualifier": "enables", "term": "3-keto sterol reductase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003854", "pubmed": 1944309, "qualifier": "enables", "term": "3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004769", "pubmed": 1944309, "qualifier": "enables", "term": "steroid delta-isomerase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016616", "qualifier": "enables", "term": "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor"}, {"category": "MF", "evidence": "IEA", "id": "GO:0047024", "qualifier": "enables", "term": "5alpha-androstane-3beta,17beta-diol dehydrogenase activity"}]}, "homologene": {"genes": [[9544, 713091], [9598, 469446], [9606, 3283], [10090, 15493], [10090, 15494], [10090, 15497]], "id": 133013}, "interpro": [{"desc": "3-beta hydroxysteroid dehydrogenase/isomerase", "id": "IPR002225", "short_desc": "3Beta_OHSteriod_DH/Estase"}, {"desc": "NAD(P)-binding domain superfamily", "id": "IPR036291", "short_desc": "NAD(P)-bd_dom_sf"}], "ipi": ["IPI00246994", "IPI00843838"], "map_location": "1p12", "name": "hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1", "other_names": ["3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1", "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I", "3-beta-HSD I", "3-beta-hydroxy-5-ene steroid dehydrogenase", "3-beta-hydroxy-Delta(5)-steroid dehydrogenase", "3-beta-hydroxysteroid 3-dehydrogenase", "delta-5-3-ketosteroid isomerase", "dihydrotestosterone oxidoreductase", "progesterone reductase", "short chain dehydrogenase/reductase family 11E, member 1", "steroid Delta-isomerase", "trophoblast antigen FDO161G"], "pantherdb": {"HGNC": "5217", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "96236", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "Q61767"}, {"MGI": "3782634", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "E9Q007"}, {"MGI": "104645", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "Q61694"}, {"RGD": "2838", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10116, "uniprot_kb": "P27364"}, {"MGI": "96233", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "P24815"}, {"RGD": "1592771", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10116, "uniprot_kb": "P22072"}, {"RGD": "1308676", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10116, "uniprot_kb": "P22071"}, {"MGI": "96235", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "P26150"}, {"MGI": "96234", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "P26149"}, {"MGI": "109598", "ortholog_type": "LDO", "panther_family": "PTHR10366", "taxid": 10090, "uniprot_kb": "O35469"}, {"RGD": "67377", "ortholog_type": "LDO", "panther_family": "PTHR10366", "taxid": 10116, "uniprot_kb": "Q62878"}, {"Ensembl": "ENSGALG00000050866", "ortholog_type": "LDO", "panther_family": "PTHR10366", "taxid": 9031, "uniprot_kb": "A0A3Q3ALY0"}, {"ZFIN": "ZDB-GENE-030828-2", "ortholog_type": "LDO", "panther_family": "PTHR10366", "taxid": 7955, "uniprot_kb": "F1QR80"}, {"ZFIN": "ZDB-GENE-081105-30", "ortholog_type": "LDO", "panther_family": "PTHR10366", "taxid": 7955, "uniprot_kb": "F1QSA2"}, {"FlyBase": "FBgn0036698", "ortholog_type": "O", "panther_family": "PTHR10366", "taxid": 7227, "uniprot_kb": "Q9VVE3"}], "uniprot_kb": "P14060"}, "pathway": {"humancyc": [{"id": "PWY-7299", "name": "progesterone biosynthesis"}, {"id": "PWY-7305", "name": "superpathway of steroid hormone biosynthesis"}, {"id": "PWY66-378", "name": "androgen biosynthesis"}], "kegg": [{"id": "hsa00140", "name": "Steroid hormone biosynthesis - Homo sapiens (human)"}, {"id": "hsa04913", "name": "Ovarian steroidogenesis - Homo sapiens (human)"}, {"id": "hsa04925", "name": "Aldosterone synthesis and secretion - Homo sapiens (human)"}, {"id": "hsa04927", "name": "Cortisol synthesis and secretion - Homo sapiens (human)"}, {"id": "hsa04934", "name": "Cushing syndrome - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-193048", "name": "Androgen biosynthesis"}, {"id": "R-HSA-193993", "name": "Mineralocorticoid biosynthesis"}, {"id": "R-HSA-194002", "name": "Glucocorticoid biosynthesis"}, {"id": "R-HSA-196071", "name": "Metabolism of steroid hormones"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}], "smpdb": [{"id": "SMP00068", "name": "Androgen and Estrogen Metabolism"}, {"id": "SMP00130", "name": "Steroidogenesis"}, {"id": "SMP00356", "name": "17-Beta Hydroxysteroid Dehydrogenase III Deficiency"}, {"id": "SMP00371", "name": "Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH"}, {"id": "SMP00372", "name": "Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency"}, {"id": "SMP00373", "name": "Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency"}, {"id": "SMP00565", "name": "Aromatase deficiency"}, {"id": "SMP00566", "name": "17-alpha-hydroxylase deficiency (CYP17)"}, {"id": "SMP00575", "name": "11-beta-hydroxylase deficiency (CYP11B1)"}, {"id": "SMP00576", "name": "21-hydroxylase deficiency (CYP21)"}, {"id": "SMP00577", "name": "Corticosterone methyl oxidase I deficiency (CMO I)"}, {"id": "SMP00578", "name": "Corticosterone methyl oxidase II deficiency - CMO II"}, {"id": "SMP00717", "name": "Apparent mineralocorticoid excess syndrome"}, {"id": "SMP00718", "name": "3-Beta-Hydroxysteroid Dehydrogenase Deficiency"}], "wikipathways": [{"id": "WP2355", "name": "Corticotropin-releasing hormone signaling pathway"}, {"id": "WP4523", "name": "Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism"}, {"id": "WP4756", "name": "Renin-angiotensin-aldosterone system (RAAS)"}, {"id": "WP4871", "name": "Kisspeptin-kisspeptin receptor system in the ovary"}, {"id": "WP496", "name": "Steroid Biosynthesis"}]}, "pfam": "PF01073", "pharmgkb": "PA29486", "pharos": {"target_id": 1074, "tdl": "Tchem"}, "pir": "A36551", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167863", "relationship": "is"}, {"id": "GNF178769", "relationship": "is"}, {"id": "GNF189675", "relationship": "is"}, {"id": "GNF200581", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF159882", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF047474", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF006737", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF105081", "relationship": "is"}, {"id": "GNF144728", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_050909.1"], "protein": ["NP_000853.1", "NP_001315544.1"], "rna": ["NM_000862.3", "NM_001328615.1"], "translation": [{"protein": "NP_000853.1", "rna": "NM_000862.3"}, {"protein": "NP_001315544.1", "rna": "NM_001328615.1"}]}, "reporter": {"HG-U133_Plus_2": ["204515_at", "241111_at"], "HG-U95Av2": "35721_at", "HTA-2_0": "TC01001040.hg.1", "HuEx-1_0": ["2354433", "2354553"], "HuGene-1_1": "7904421"}, "summary": "The protein encoded by this gene is an enzyme that catalyzes the oxidative conversion of delta-5-3-beta-hydroxysteroid precursors into delta-4-ketosteroids, which leads to the production of all classes of steroid hormones. The encoded protein also catalyzes the interconversion of 3-beta-hydroxy- and 3-keto-5-alpha-androstane steroids. [provided by RefSeq, Jun 2016].", "symbol": "HSD3B1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1415742"}, "unigene": "Hs.364941", "uniprot": {"Swiss-Prot": "P14060", "TrEMBL": "E9PRN7"}, "wikipedia": {"url_stub": "HSD3B1"}}